Extra-viral DNA in adeno-associated viral vector preparations induces TLR9-dependent innate immune responses in human plasmacytoid dendritic cells

被引:0
|
作者
Kirsten Bucher
Eduardo Rodríguez-Bocanegra
Bernd Wissinger
Torsten Strasser
Simon J. Clark
Andreas L. Birkenfeld
Dorothea Siegel-Axel
M. Dominik Fischer
机构
[1] University Hospital Tübingen,University Eye Hospital, Centre for Ophthalmology
[2] University Hospital Tübingen,Institute for Ophthalmic Research, Centre for Ophthalmology
[3] University of Tübingen,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health
[4] University of Manchester,Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine IV
[5] Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich,Oxford Eye Hospital
[6] German Center for Diabetes Research (DZD),Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences
[7] University Hospital of Tübingen,undefined
[8] Oxford University NHS Foundation Trust,undefined
[9] University of Oxford,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Adeno-associated viral (AAV) vector suspensions produced in either human derived HEK cells or in Spodoptera frugiperda (Sf9) insect cells differ in terms of residual host cell components as well as species-specific post-translational modifications displayed on the AAV capsid proteins. Here we analysed the impact of these differences on the immunogenic properties of the vector. We stimulated human plasmacytoid dendritic cells with various lots of HEK cell-produced and Sf9 cell-produced AAV-CMV-eGFP vectors derived from different manufacturers. We found that AAV8-CMV-eGFP as well as AAV2-CMV-eGFP vectors induced lot-specific but not production platform-specific or manufacturer-specific inflammatory cytokine responses. These could be reduced or abolished by blocking toll-like receptor 9 signalling or by enzymatically reducing DNA in the vector lots using DNase. Successful HEK cell transduction by DNase-treated AAV lots and DNA analyses demonstrated that DNase did not affect the integrity of the vector but degraded extra-viral DNA. We conclude that both HEK- and Sf9-cell derived AAV preparations can contain immunogenic extra-viral DNA components which can trigger lot-specific inflammatory immune responses. This suggests that improved strategies to remove extra-viral DNA impurities may be instrumental in reducing the immunogenic properties of AAV vector preparations.
引用
收藏
相关论文
共 44 条
  • [31] Genetic Modification of Adeno-Associated Viral Vector Type 2 Capsid Enhances Gene Transfer Efficiency in Polarized Human Airway Epithelial Cells
    White, April F.
    Mazur, Marina
    Sorscher, Eric J.
    Zinn, Kurt R.
    Ponnazhagan, Selvarangan
    HUMAN GENE THERAPY, 2008, 19 (12) : 1407 - 1414
  • [32] Transcriptional Changes in Non-Human Primate Tissues After Intrathecal Delivery of Serotype 9 Adeno-Associated Viral Vector: Insights into Organ Toxicities
    Aihara, Fumiaki
    Mardo, Matthew
    Ruda, Vera
    Onishi-Seebacher, Megumi
    Couttet, Philippe
    Mansfield, Keith
    Penraat, Kelley
    Hudry, Eloise
    MOLECULAR THERAPY, 2024, 32 (04) : 128 - 128
  • [33] Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells
    Xin, Ke-Qin
    Mizukami, Hiroaki
    Urabe, Masashi
    Toda, Yoshihiko
    Shinoda, Kaori
    Yoshida, Atsushi
    Oomura, Kenji
    Kojima, Yoshitsugu
    Ichino, Motohide
    Klinman, Dennis
    Ozawa, Keiya
    Okuda, Kenji
    JOURNAL OF VIROLOGY, 2006, 80 (24) : 11899 - 11910
  • [34] Sequential Adeno-Associated Viral Vector Serotype 9-Green Fluorescent Protein Gene Transfer Causes Massive Inflammation and Intense Immune Response in Rat Striatum
    Yang, Chun
    Hao, Fei
    He, Jun
    Lu, Tao
    Klein, Ronald L.
    Zhao, Li-Ru
    Duan, Wei-Ming
    HUMAN GENE THERAPY, 2016, 27 (07) : 528 - 543
  • [35] A comparison of in vivo viral targeting systems identifies adeno-associated virus serotype 9 (AAV9) as an effective vector for genetic manipulation of Leydig cells in adult mice
    Darbey, Annalucia
    Rebourcet, Diane
    Curley, Michael
    Kilcoyne, Karen
    Jeffery, Nathan
    Reed, Natalie
    Milne, Laura
    Roesl, Cornelia
    Brown, Pamela
    Smith, Lee B.
    ANDROLOGY, 2021, 9 (01) : 460 - 473
  • [36] CpG DNA-triggered upregulation of TLR9 expression affects apoptosis and immune responses in human plasmacytoid dendritic cells isolated from chronic hepatitis B patients
    Zhu, Bin
    Wang, Tianbao
    Wei, Xiaoxia
    Zhou, Yancai
    Li, Jiansheng
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 129 (02) : 330 - 337
  • [37] Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells
    Zhu, Xiaotong
    Liu, Zhihao
    Liu, Jin-Qing
    Zhu, Jianmin
    Zhang, Jianchao
    Davis, Jonathan P.
    Chu, Jianhong
    Yu, Jianhua
    Zhou, Jie
    Li, Ming-Song
    Bai, Xue-Feng
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (02) : 403 - 411
  • [38] Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks
    Veldwijk, MR
    Schiedlmeier, B
    Kleinschmidt, JA
    Zeller, WJ
    Fruehauf, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (07) : 1136 - 1142
  • [39] Superior gene transfer into solid tumor cells than into human mobilized peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks.
    Veldwijk, MR
    Schiedlmeier, B
    Kleinschmidt, JA
    Zeller, WJ
    Fruehauf, S
    BLOOD, 1999, 94 (10) : 417B - 417B
  • [40] CAP-GT Platform: A Scalable AAV Production System Using Helper Virus-Free Adeno-Associated Viral Vector Packaging/Producer Cell Lines Based in Human Suspension Cells
    Goncalves, Ines do Carmo
    Hein, Kerstin
    Hudjetz, Ben
    Strempel, Nikola
    Riebesehl, Nina
    Kewes, Helmut
    Bauer, Thu
    Bialek, Corinna
    Wissing, Silke
    Faust, Nicole
    MOLECULAR THERAPY, 2019, 27 (04) : 224 - 225